Skip to content
Review Open access

Acute‑on‑chronic kidney disease (AoCKD): a critical appraisal and call for action to define boundaries and optimize management

Oct 2026 · Renal Failure · Vol 48 · 0 citations · 64 references
Medicine

TL;DR

Harmonized definitions, incorporation of cystatin‑C–based markers, structured imaging pathways, and integration of early biomarkers are urgently needed.

Abstract

Abstract Acute‑on‑chronic kidney disease (AoCKD) refers to an acute decline in renal function occurring in individuals with established CKD. Despite its major clinical impact—including increased mortality, accelerated CKD progression, and higher cardiovascular risk—AoCKD remains underrepresented within major guideline frameworks (KDIGO, ADQI, NICE). Our review aims to critically appraise existing guideline frameworks, definitions, biomarkers, imaging recommendations, and research gaps related to AoCKD, and to highlight priorities for future harmonization and clinical integration. We conducted a targeted literature search of PubMed, Embase, and the Cochrane Library, to identify guidelines, consensus reports, observational studies, and systematic reviews describing acute deterioration in CKD. Extracted data included definitional criteria, epidemiology, biomarker performance, imaging guidance, and prognostic outcomes. Current KDIGO, ADQI, and NICE frameworks were evaluated in parallel. We report marked heterogeneity in definitions describing acute deterioration in CKD, with terms including AoCKD, AKI‑on‑CKD, acute pre‑existing kidney dysfunction, and cROCK‑based definitions. Reported incidence varies widely (1–33%) due to inconsistent criteria. Creatinine‑based definitions show reduced prognostic accuracy in CKD populations, whereas cystatin‑C–based eGFR demonstrates superior discrimination for mortality and progression. We propose an operational definition of AoCKD that includes functional criteria and biomarker-based criteria. The definition reflects the increased mortality in this phenotype even before reaching the KDIGO-AKI threshold. In conclusion, AoCKD is a clinically significant but poorly defined state within the kidney disease continuum. Harmonized definitions, incorporation of cystatin‑C–based markers, structured imaging pathways, and integration of early biomarkers are urgently needed.

Read PDF

Similar papers

Review Open access Sep 2026

Evaluation and Management of Anemia in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2026 Clinical Practice Guideline.

Key points include the use of transferrin saturation and ferritin thresholds to guide iron therapy, with intravenous iron preferred over oral iron in people receiving hemodialysis and addressing correctable causes of anemia before use of an ESA or a HIF-PHI.

S. Hedayati, Jodie L. Babitt, Jeffrey S. Berns et al. · 0 citations
Review Oct 2026

Furosemide Stress Test in Adults and Children With Acute Kidney Injury: A Systematic Review and Meta-Analysis.

OBJECTIVES To evaluate the diagnostic accuracy and therapeutic utility of the furosemide stress test (FST) for acute kidney injury (AKI) management in critically ill adults and children. DATA SOURCES PubMed, Embase, Scopus, and Cochrane Central Register of Controlled Trials were searched from inception to March 3, 20...

Phu Nguyen Trong Tran, Hoang Minh Luong, Nhan Duc Doan · 0 citations
Open access Oct 2026

Acute kidney disease after acute kidney injury: incidence, risk factors, and association with de novo chronic kidney disease

Abstract Acute Kidney Disease (AKD) is defined as acute kidney injury (AKI) persisting for 7 to 90 days and represents a window for interventions to improve renal outcomes. However, data on AKD remain underexplored. This retrospective cohort study at Tongji Hospital, China, included 23,868 adult patients who survived a...

Su-Jia Hu, Xing-Yang Zhao, Yi-Chun Cheng et al. · 0 citations
Meta-analysis Open access Oct 2026

Prognostic value of multiple biomarkers for kidney function decline in type 2 diabetes with relatively preserved kidney function: a systematic review and exploratory meta-analysis

Background Diabetic kidney disease (DKD) is a dominant driver of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Current risk assessment tools, however, lack adequate sensitivity for early disease detection. This study evaluated the prognostic value of multiple biomarkers for kidney function decline in...

Jie Hu, Xin-Yu Pan, Shu-Wu Wei et al. · 0 citations
Open access Oct 2026

Acute Kidney Disease and Clinical Outcomes in Stable Outpatients With Decompensated Cirrhosis: A Prospective Cohort Study.

Background/Aims Acute kidney disease (AKD), as recently redefined by the Acute Disease Quality Initiative-International Club of Ascites (ADQI-ICA) consensus, captures persistent or subacute kidney dysfunction often following acute kidney injury (AKI). Its prognostic relevance in stable outpatients with decompensated ci...

V. Lekakis, F. Wong, G. Papatheodoridis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.